← All beauty signals
Governance

The Consent Tax

Illinois courts have absorbed eight years of biometric-privacy suits against beauty’s AI face-scanning tools. In 2026 a federal appeals ruling capped recovery at one violation per person.

What is it?

Beauty’s AI face-scanning tools — skin-diagnostic apps, website virtual try-on, and in-store kiosks — turn a camera image into a biometric read, which pulls them under Illinois’s privacy law. Eight years of suits have followed. In 2026 the arithmetic changed: a damages cap arrived, but the docket didn’t quiet.

Why now?

A federal appeals court made BIPA’s 2024 damages amendment retroactive, capping recovery at one violation per person rather than per scan — a ceiling, not an exit. New suits still arrive: JCPenney was sued in March, MAC’s motion to dismiss failed in June. The risk is priced now, not open-ended.

Who’s building it?

Beauty retailers deploy the scanning tools; their technology vendors supply them but often escape the suit entirely.

Beauty retailersScan-tool vendorsIllinois plaintiffsFederal courtsInsurers
The full read
Why now, who is building it, where the market goes, and what stays unsettled.
Get weekly →
01 · The market
Who’s in it
Defendants — beauty retailers and the vendors who built their scanners.
Claimants — Illinois residents who tried a skin-diagnostic app, try-on tool, or kiosk.
Courts — federal judges weighing identifiability, jurisdiction, and now the damages cap.
What’s at stake
The docket keeps growing even as the 2026 ruling capped what any single plaintiff can recover per person.
Which tool type draws the next suit is unpredictable.
A settlement’s deletion term is the rare hard commitment.
What’s unsettled
Whether any company besides Neutrogena will ever actually commit to deletion.
Whether the damages cap will slow new filings at all.
Whether liability sits with the retailer, the vendor, or gets split between them.
02 · How the demand matureda progression, not a timeline
Filing
Suits arrive against a new tool before the theory is tested.
Survival
denied motion to dismiss turns a filing into a real case.
Settlement
A dollar figure attaches, and with it a template for what real compliance and deletion require.
Doctrine
An appeals ruling sets the ceiling the whole pending docket must share.
03 · Where the market goesthe forks, not a prediction
→Whether liability keeps falling on retailers alone, or contracts finally start shifting it back to the vendors who built the tools.
→Whether the 2026 damages cap actually slows new filings, or simply changes their math.
→Whether skin-diagnostic apps become the busier front, now that virtual try-on has posted its one real defence win.
→Whether another state ever grants residents the private right of action Illinois has.
The suits and the ceiling are both real, moving in opposite directions at once — and whether that squeeze changes anyone’s practice is still unproven.
04 · The Illinois BIPA Docket deskthree tool types, one statute
The Diagnostic Settlement
A dollar figure attaches to Skin360.
$4.7 million to ~11,000 Illinois users, images deleted.
Cosmetics Business
The Suit Spanning Two Tools
MAC’s kiosk and website tool face one suit.
Motion to dismiss denied, case proceeds to discovery, June 2026.
Personal Care Insights
Where the Docket Began
A kiosk vendor escaped; the retailer stayed defendant.
Sephora sued 2018; ModiFace dismissed for lack of jurisdiction.
Global Cosmetics News
05 · The Wire
01
An appeals court capped BIPA recovery at one per person.
FindLaw Caselaw ↗
02
Kenvue agreed $4.7m over Neutrogena Skin360 face scans
Cosmetics Business ↗
03
MAC Cosmetics’ motion to dismiss was denied, letting its suit over an in-store scanner and a website try-on tool proceed toward discovery.
Personal Care Insights ↗
04
The earliest case in this line, over Sephora’s in-store Visual Artist Kiosk, shows the in-store-kiosk fact pattern is distinct from a website tool — its vendor escaped the suit on jurisdiction while Sephora did not.
Global Cosmetics News ↗
05
A 2024 ruling dismissed the Estée Lauder virtual try-on suit.
Paul Hastings ↗
The panel on this signal
They agreed on
–New suits keep landing on this docket even as the 2026 ruling capped what any one can recover.
–Three distinct tool types face three distinct legal outcomes.
–Only one settlement has actually confirmed a company will delete what it collected.
The vendor-contracts counsel disagreed on
–This reads like straightforward retailer liability, but Sephora shows the real fight is which contract clause allocates the loss.
Know more about the method →
✦How this signal was built
01 · Panel
A Delphi panel of 4 AI analysts, each reasoning independently.
→
02 · Debate
They challenge and revise each other’s reads over two rounds.
→
03 · Evidence
Every claim is tied to a cited, linked source on The Wire.
→
04 · Synthesis
A moderator writes it into one read, disagreement and all.